an announcement a few days ago that ambroxol hydrochloride sustained-release tablets, lactulose oral solution, boulardii yeast powder and amino sulfate Potassium glucose capsules are converted from prescription drugs to over-the-counter drugs
5 kinds of drugs including ambroxol hydrochloride sustained-release tablets and lactulose oral solution were converted to over-the-counter drugs
Time of Update: 2021-08-03
Attached variety list Medical Network, July 15 News On July 14, the State Food and Drug Administration issued the "Announcement on the Conversion of 4 Drugs Prescription Drugs Including Ambroxol Hydrochloride Sustained Release Tablets to Over-the-Counter Drugs (2021 No.
Kelun Pharmaceutical: Moxifloxacin Hydrochloride Eye Drops Obtained Drug Registration Approval
Time of Update: 2021-07-09
On April 15th, Kelun Pharmaceutical issued an announcement stating that the chemical drug "Moxifloxacin Hydrochloride Eye Drops" of its subsidiary Jiangxi Kelun Pharmaceutical Co.
Hisun Pharmaceutical: Moxifloxacin Hydrochloride Tablets Obtained Drug Registration Certificate
Time of Update: 2021-06-11
The company moxifloxacin hydrochloride tablets according to the new Class 4 State Food and Drug Administration approved for marketing, as if by conformance assessment.
Cornbey hydrochloride oral solution was approved for drug registration.
Time of Update: 2020-07-28
The oral solution of amsulcate hydrochloride is a commonly used drug of phlegm which has been included in the National Health Insurance Directory (annual edition) category as class B drugs. Specifications applicable to acute, chronic bronchitis
R & D Daily: moxifloxacin hydrochloride injection approved for marketing
Time of Update: 2020-01-15
Skyrizi's head to head phase 3 research reached the end point; Zhendong pharmaceutical's paracetamol tablet has been evaluated; Huabang pharmaceutical's bensulfobertastine tablet
Moxifloxacin hydrochloride injection approved for marketing
Time of Update: 2020-01-15
On January 15, Peking University Pharmaceutical announced that the company had received the registration approval of moxifloxacin hydrochloride injection approved and issued
Kelun pharmaceutical "moxifloxacin hydrochloride and sodium chloride injection" obtained the drug registration approval
Time of Update: 2019-05-06
Moxifloxacin hydrochloride and sodium chloride injection are mainly used to treat adult upper and lower respiratory tract infections, skin and soft tissue infections, complex abdominal infections, including mixed bacterial infections.
Moxifloxacin hydrochloride tablets approved for marketing by Guowei Pharmaceutical Co., Ltd. are deemed to have passed the consistency evaluation
Time of Update: 2019-01-14
On January 11, the official website of Sichuan Guowei pharmaceutical company announced that the second tablet variety "moxifloxacin hydrochloride tablet" applied by its company
Moxifloxacin hydrochloride tablets of Haizheng Pharmaceutical Co., Ltd. passed who PQ certification
Time of Update: 2018-11-16
According to the confirmation letter, moxifloxacin hydrochloride tablets produced by the company have passed the PQ certification of who and have been listed in the list of who recommended procurement.